These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 3007578)

  • 21. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP.
    Cattaneo M; Zighetti ML; Lombardi R; Mannucci PM
    Br J Haematol; 1994 Dec; 88(4):826-9. PubMed ID: 7819105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of monoclonal antibodies against von Willebrand factor and platelet glycoproteins IIb/IIIa on the platelet retention test.
    McPherson J; Brownlea S; Zucker MB
    Blood; 1987 Aug; 70(2):546-50. PubMed ID: 3496929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.
    Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y
    J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of von Willebrand factor-platelet interaction by fibrinogen.
    Piétu G; Cherel G; Marguerie G; Meyer D
    Nature; 1984 Apr 12-18; 308(5960):648-9. PubMed ID: 6324004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
    Parker RI; Gralnick HR
    Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor.
    Savage B; Shattil SJ; Ruggeri ZM
    J Biol Chem; 1992 Jun; 267(16):11300-6. PubMed ID: 1597464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S; Gralnick H
    Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.
    Parker RI; Gralnick HR
    Blood; 1986 Sep; 68(3):732-6. PubMed ID: 3017478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of platelet function.
    Bennett JS; Kolodziej MA
    Dis Mon; 1992 Aug; 38(8):577-631. PubMed ID: 1321709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
    Ikeda Y; Handa M; Kawano K; Kamata T; Murata M; Araki Y; Anbo H; Kawai Y; Watanabe K; Itagaki I
    J Clin Invest; 1991 Apr; 87(4):1234-40. PubMed ID: 2010539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
    Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
    Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
    Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
    Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
    Gralnick HR; Williams SB; Coller BS
    Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.